provides early screening for Alzheimer’s Disease with 98% accuracy of cognitive impairment

by / Wednesday, 21 January 2009 / Published in Uncategorized

Two months after launch, has served thousands of users in 32 states and 4 countries

Developed by Dr. John H. Dougherty, a leading neurologist, founder of Medinteract and Medical Director of the Cole Neuroscience Center at UT Medical Center in Knoxville, the ALZselftest empowers people to monitor their cognitive health and identify potential problems as early as possible.
Since its launch in November 2008, has steadily grown in popularity, averaging more than 2200 visitors each week. Once visiting, users find a wealth of information about Alzheimer’s Disease. The ALZselftest, proven to be 98% accurate in clinical studies for diagnosing cognitive impairment, can be taken in about 10 minutes and is available for only $20. To-date, tests have been taken by users in 32 states and 4 countries.
Ongoing clinical studies of the ALZselftest show it is 98% accurate in distinguishing those with cognitive impairment from non-impaired persons. This rate is achieved because ALZselftest measures all of the cognitive domains, unlike other Alzheimer’s tests. It also has shown 95% accuracy at distinguishing between the stages of Alzheimer’s, including Mild Cognitive Impairment.  By contrast, the widely used screening test, MMSE, only reaches 67% diagnostic accuracy.
According to the National Institute on Aging, scientists estimate nearly 5 million Americans currently suffer from AD. “The earlier you diagnose Alzheimer’s Disease, the better your chances of managing the disease without severe impairment,” says Dr. Dougherty. “Unfortunately, 60% of people with early signs of the disease go undiagnosed until they are past the early stages, when treatment options are best. Our goal was to make low-cost screening available to the general public so they can monitor their cognitive health, just as they would monitor blood pressure or blood sugar levels.” 
In January, partnered with the American Museum of Science and Energy to provide a free Alzheimer’s Disease presentation and screening tests, funded by the MetLife Foundation, for almost 100 senior adults in less than two hours. According to Dr. Dougherty, “Partnering with the American Museum of Science and Energy gave us the opportunity to educate and assist so many folks that we would not have reached otherwise. We’re currently looking for other organizations to partner with to maximize our impact with the public.” 
The test, research and supporting statistical data, as well as comprehensive resources for those wishing to learn more about AD, are available at